- Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker. Barron’s
- Moderna stock down premarket on mixed 2024 earnings Yahoo Finance
- Moderna beats on revenue but loses more than expected as it scales down manufacturing CNBC
- Moderna reports $238M manufacturing write-down as cuts, new vaccines shape 2025 Endpoints News
- Moderna Earnings Reveal Dramatic Shift: Cost-Cutting Success vs $1.1B Loss – Full Analysis StockTitan
Powered by WPeMatico